Understanding and identifying ways to improve hospital-based cancer care and treatment for people with dementia: an ethnographic study.


Journal

Age and ageing
ISSN: 1468-2834
Titre abrégé: Age Ageing
Pays: England
ID NLM: 0375655

Informations de publication

Date de publication:
08 01 2021
Historique:
received: 28 01 2020
pubmed: 7 11 2020
medline: 29 7 2021
entrez: 6 11 2020
Statut: ppublish

Résumé

Providing cancer care and treatment for ageing populations with complicating comorbidities like dementia is a growing global challenge. This study aimed to examine the hospital-based cancer care and treatment challenges and support needs of people with dementia, and identify potential ways to address these. A two-site ethnographic study in England involving semi-structured interviews, observations and accompanying conversations, and medical record review. Participants (N = 58) were people with dementia and comorbid cancer (n = 17), informal caregivers (n = 22) and hospital staff (n = 19). Ethnographically informed thematic analysis was conducted. There was an accumulated complexity of living with both illnesses simultaneously. People with dementia and families could feel confused and uninformed due to difficulties understanding, retaining and using cancer information, which impacted their informed treatment decision-making. Dementia increased the complexity and burden of travelling to and navigating unfamiliar hospital environments, frequent lengthy periods of waiting in hospital, and self-managing symptoms and side-effects at home. Oncology staff were often working without the full picture, due to variable documenting of dementia in medical records, dementia training was limited, and time and resource pressures impeded the highly individualised, flexible cancer care required by people with dementia. Supportive family carers were crucial in enabling people with dementia to access, navigate and undergo cancer treatment and care. Dementia complicates cancer care in a range of ways accumulating across the cancer pathway. Our findings suggest there are several strategies and interventions, which we list here, with potential to improve cancer care and treatment for people with dementia and their families.

Sections du résumé

BACKGROUND
Providing cancer care and treatment for ageing populations with complicating comorbidities like dementia is a growing global challenge. This study aimed to examine the hospital-based cancer care and treatment challenges and support needs of people with dementia, and identify potential ways to address these.
METHODS
A two-site ethnographic study in England involving semi-structured interviews, observations and accompanying conversations, and medical record review. Participants (N = 58) were people with dementia and comorbid cancer (n = 17), informal caregivers (n = 22) and hospital staff (n = 19). Ethnographically informed thematic analysis was conducted.
RESULTS
There was an accumulated complexity of living with both illnesses simultaneously. People with dementia and families could feel confused and uninformed due to difficulties understanding, retaining and using cancer information, which impacted their informed treatment decision-making. Dementia increased the complexity and burden of travelling to and navigating unfamiliar hospital environments, frequent lengthy periods of waiting in hospital, and self-managing symptoms and side-effects at home. Oncology staff were often working without the full picture, due to variable documenting of dementia in medical records, dementia training was limited, and time and resource pressures impeded the highly individualised, flexible cancer care required by people with dementia. Supportive family carers were crucial in enabling people with dementia to access, navigate and undergo cancer treatment and care.
CONCLUSIONS
Dementia complicates cancer care in a range of ways accumulating across the cancer pathway. Our findings suggest there are several strategies and interventions, which we list here, with potential to improve cancer care and treatment for people with dementia and their families.

Identifiants

pubmed: 33156901
pii: 5958499
doi: 10.1093/ageing/afaa210
pmc: PMC7793597
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

233-241

Subventions

Organisme : Department of Health
ID : PB-PG-0816-20015
Pays : United Kingdom

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Références

Patient Relat Outcome Meas. 2015 Mar 27;6:117-26
pubmed: 25848328
Aging Ment Health. 2018 Oct;22(10):1254-1271
pubmed: 28718298
Int J Cancer. 2019 Jan 1;144(1):49-58
pubmed: 29978474
Nat Rev Clin Oncol. 2019 Dec;16(12):746-761
pubmed: 31350467
BMJ Open. 2019 Sep 3;9(9):e029105
pubmed: 31481553
BMJ Open. 2017 Feb 3;7(2):e011146
pubmed: 28159845
JMIR Form Res. 2019 Mar 12;3(1):e11111
pubmed: 30860487
Gerontologist. 2017 Aug 1;57(4):e62-e74
pubmed: 27831481
J Comorb. 2019 Aug 22;9:2235042X19870934
pubmed: 31489279
Eur J Cancer Care (Engl). 2011 Jul;20(4):555-60
pubmed: 21501264
J Geriatr Oncol. 2020 Sep;11(7):1125-1131
pubmed: 32253158
Psychooncology. 2020 Aug;29(8):1347-1354
pubmed: 32567082
PLoS Med. 2006 Jul;3(7):e193
pubmed: 16805649
Psychooncology. 2018 Apr;27(4):1121-1128
pubmed: 29178602
BMJ Open. 2018 Apr 12;8(4):e020250
pubmed: 29654025
Psychooncology. 2016 Oct;25(10):1137-1146
pubmed: 27246507
Age Ageing. 2019 May 1;48(3):361-367
pubmed: 30403771
Qual Health Res. 2018 Apr;28(5):813-823
pubmed: 29082800
Psychooncology. 2016 Sep;25(9):1079-84
pubmed: 27423160

Auteurs

Laura Ashley (L)

Leeds School of Social Sciences, Leeds Beckett University, Leeds, UK.

Rachael Kelley (R)

Centre for Dementia Research, School of Health and Community Studies, Leeds Beckett University, Leeds, UK.

Alys Griffiths (A)

Centre for Dementia Research, School of Health and Community Studies, Leeds Beckett University, Leeds, UK.

Fiona Cowdell (F)

Faculty of Health, Education and Life Sciences, Birmingham City University, Birmingham, UK.

Ann Henry (A)

Clinical Oncology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
School of Medicine, University of Leeds, Leeds, UK.

Hayley Inman (H)

Oncology Services, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK.

Ellen Mason (E)

Clinical Trials Research Unit, Institute of Clinical Trials Research, University of Leeds, Leeds, UK.

Michelle Collinson (M)

Clinical Trials Research Unit, Institute of Clinical Trials Research, University of Leeds, Leeds, UK.

Amanda Farrin (A)

Clinical Trials Research Unit, Institute of Clinical Trials Research, University of Leeds, Leeds, UK.

Claire Surr (C)

Centre for Dementia Research, School of Health and Community Studies, Leeds Beckett University, Leeds, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH